Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Invivyd (IVVD) Cash & Equivalents (2022 - 2025)

Invivyd filings provide 4 years of Cash & Equivalents readings, the most recent being $226.7 million for Q4 2025.

  • On a quarterly basis, Cash & Equivalents rose 226.88% to $226.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $226.7 million, a 226.88% increase, with the full-year FY2025 number at $226.7 million, up 226.88% from a year prior.
  • Cash & Equivalents hit $226.7 million in Q4 2025 for Invivyd, up from $85.0 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $226.7 million in Q4 2025 to a low of $34.9 million in Q2 2025.
  • Median Cash & Equivalents over the past 4 years was $121.9 million (2023), compared with a mean of $125.5 million.
  • The widest YoY moves for Cash & Equivalents: up 226.88% in 2025, down 76.4% in 2025.
  • Invivyd's Cash & Equivalents stood at $92.1 million in 2022, then surged by 117.91% to $200.6 million in 2023, then tumbled by 65.44% to $69.3 million in 2024, then skyrocketed by 226.88% to $226.7 million in 2025.
  • The last three reported values for Cash & Equivalents were $226.7 million (Q4 2025), $85.0 million (Q3 2025), and $34.9 million (Q2 2025) per Business Quant data.